ATC code L
From Wikipedia, the free encyclopedia
ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QL...[2]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| L Antineoplastic and immunomodulating agents | ||
|---|---|---|
| L01 Antineoplastic agents | ||
| L02 Endocrine therapy | ||
| L03 Immunostimulants | ||
| L04 Immunosuppressants | ||
|
References[edit]
- ^ "ATC/DDD Index 2016: code L". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2016: code QL". WHO Collaborating Centre for Drug Statistics Methodology.
|
|
|
|
|
